Pernicious anemia and Vitamin Bdeficiency anemia: 12

The VA rates Pernicious anemia and Vitamin Bdeficiency anemia: 12 under Diagnostic Code 7722 at 10%, 100%. The minimum 10% rating requires: Requiring continuous treatment with Vitamin Binjections, Vitamin Bsublingual or high-dose oral tablets, or Vitamin Bnasal spray or gel 12 12 12. The maximum 100% rating requires: For initial diagnosis requiring transfusion due to severe anemia, or if there are signs or symptoms related to central nervous system impairment, such as encephalopathy, myelopathy, or severe peripheral neuropathy, requiring parenteral Btherapy 12.

The VA rates Pernicious anemia and Vitamin Bdeficiency anemia: 12 under Diagnostic Code (DC) 7722, governed by 38 CFR 38 CFR § 4.117. The diagnostic code establishes the specific rating tiers and severity criteria the VA examiner applies.

A 10% rating requires: Requiring continuous treatment with Vitamin Binjections, Vitamin Bsublingual or high-dose oral tablets, or Vitamin Bnasal spray or gel 12 12 12. A 100% rating requires: For initial diagnosis requiring transfusion due to severe anemia, or if there are signs or symptoms related to central nervous system impairment, such as encephalopathy, myelopathy, or severe peripheral neuropathy, requiring parenteral Btherapy 12. The difference typically reflects the frequency, severity, or functional impact of the condition as documented in medical records and C&P examination findings.

Yes — a 100% rating for Pernicious anemia and Vitamin Bdeficiency anemia: 12 alone meets the single-disability threshold for TDIU (38 CFR § 4.16). If the condition prevents substantially gainful employment, the veteran is compensated at the 100% rate without a schedular 100% rating.

The key evidence for Pernicious anemia and Vitamin Bdeficiency anemia: 12 is documentation of how the condition affects daily functioning. Treatment records showing worsening symptoms, functional limitations documented by your provider, and buddy statements describing observable impact on daily life all strengthen the claim. A nexus letter from a qualified medical professional linking the current severity to service is essential for contested claims.

The C&P examiner uses a Hematologic & Lymphatic System DBQ and evaluates your condition against the DC 7722 rating criteria. The examiner documents symptom frequency, severity, and functional impact. Bring all treatment records and describe your worst days, not your best — the VA rates on the full clinical picture across time, not a snapshot of one good day.